Patents for A61P 19 - Drugs for skeletal disorders (81,981)
09/2011
09/08/2011US20110217395 Therapeutic, Bio-Affecting And Body Treating Composition
09/08/2011US20110217394 Iridoid Based Formulations
09/08/2011US20110217388 Devices and methods for the regeneration of bony defects
09/08/2011US20110217370 Substances for promoting healthy joint function comprising glucosamine sulfate, omega-3 polyunsaturated fatty acids or derivatives thereof, and undenatured type ii collagen
09/08/2011US20110217352 Development of a human colloidal bone graft material
09/08/2011US20110217337 Bioactive agent for bone tissue engineering
09/08/2011US20110217336 Chronotherapeutic dosage forms and methods of treatment using chronotherapy
09/08/2011US20110217335 Synthesis of resorcylic acid lactones useful as therapeutic agents
09/08/2011US20110217313 Treatment of orthopedic conditions
09/08/2011US20110217310 Blockade of tl1a-dr3 interactions to ameliorate t cell mediated disease pathology
09/08/2011US20110217306 C-terminal exon 5.4 of runx1/aml1
09/08/2011US20110217302 TCR Complex Immunotherapeutics
09/08/2011US20110217291 Soluble hybrid fct receptors and related methods
09/08/2011US20110217267 Gene therapy vectors and cytosine deaminases
09/08/2011US20110217263 Expansion of haemopoietic precursors
09/08/2011US20110217251 Therapeutic compositions comprising polyhydroxyltate fatty alcohol derivatives and uses thereof
09/07/2011EP2363400A2 Novel compound with spiro chiral carbon backbone, preparation method thereof, and pharmaceutical composition containing the same
09/07/2011EP2363390A1 Derived lactam from d3 vitamin
09/07/2011EP2363140A1 Antisecretory protein for use in the treatment of compartiment syndrome
09/07/2011EP2363138A1 Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring periodontal diseases
09/07/2011EP2363132A1 The use of sophoricoside in preparing medicaments
09/07/2011EP2362771A1 Combinational therapy comprising dhodh inhibitor and methotrexate for treating autoimmune disease
09/07/2011EP2046737B1 2-methylene-1 alpha,25-dihydroxy-19,21-dinorvitamin d3 analogs and uses thereof
09/07/2011CN1883618B Effective parts of cirald daphne bark, preparation method and application thereof
09/07/2011CN1582150B Staurosporine derivatives as inhibitors of FLT3 receptor tyrosine kinase activity
09/07/2011CN102177178A Anti-IL-12/IL-23 antibodies
09/07/2011CN102176918A Treating or preventing gout
09/07/2011CN102174361A Cistanche deseuticola health-care wine and preparation method thereof
09/07/2011CN102174102A Stable analogs of peptide and polypeptide therapeutics
09/07/2011CN102174046A Tetomilast polymorphs
09/07/2011CN102174045A Tetomilast polymorphs
09/07/2011CN102174044A Tetomilast polymorphs
09/07/2011CN102172403A Method for treating interleukin-6 related diseases
09/07/2011CN102172390A Traditional Chinese medicine for treating diabetic gout
09/07/2011CN102172357A Core 2 glcnac-t inhibitors
09/07/2011CN102172356A Use of taurochenodeoxycholic acid in prevention and treatment of osteoporosis
09/07/2011CN102172350A Medical composition for preventing and/or treating bone loss
09/07/2011CN101934031B Bone-strengthening and granulation-promoting paste for treating chronic pyogenic osteomyelitis and aseptic necrosis of femoral head and preparation method thereof
09/07/2011CN101926906B Chinese medicinal composition for treating early and medium femoral necrosis
09/07/2011CN101919948B Traditional Chinese medicine compound for curing glucoticorticoid-induced avascular necrosis of the femoral head
09/07/2011CN101912458B Medicament for treating protrasion of the lumbar intervertebral disci
09/07/2011CN101843680B Application of composite containing polygonum orientale in preventing and treating climacteric diseases and delaying aging
09/07/2011CN101791318B Novel application of bacterial lipopolysaccharides
09/07/2011CN101785770B Application of methazolamide in preparing medicament for treating ankylosing spondylitis
09/07/2011CN101703624B Chinese medicinal composition for treating ankylosing spondylitis
09/07/2011CN101703605B Combined medicament for treating cervical disc protrusion and lumbar disc protrusion
09/07/2011CN101664534B External used traditional Chinese medicine for treating scapulohumeral periarthritis
09/07/2011CN101642497B Plaster for treating hyperosteogeny and bone erosion rheumatism
09/07/2011CN101513522B Chinese medical herbs aerosols for treating anchylosis, painful swelling and preparation method thereof
09/07/2011CN101474396B Pharmaceutical composition for treating rheumatism and atrophic arthritis
09/07/2011CN101455709B Medicine for waist leg, cervical vertebra, hyperosteogeny and preparation method thereof
09/07/2011CN101434657B Preparation and use of recombinant mtVEGF121/MAP30KDEL fusion noxioussubstance
09/07/2011CN101407546B Human anti-human tumor necrosis factor-alpha single chain antibody
09/07/2011CN101327280B Chinese medicine for treating paralysis
09/07/2011CN101278928B Medicament composition containing levocarnitine or its derivatives and use thereof
09/07/2011CN101138594B Quality control method of traditional chinese medicine preparation for treating traumatic injury and rheumatism ostealgia
09/07/2011CN101128210B A herbal mixture extract of rehmanniae radix preparata and acanthopanacis cortex and a composition comprising the same for prevention and treatment of osteoporosis
09/06/2011US8013156 Tie-2 modulators and methods of use
09/06/2011US8013153 Substituted pyrimidine kinase inhibitors
09/06/2011US8013124 for stimulating the immune system, and proliferation and/or development of hematopoietic cells; production of proinflammatory cytokines
09/06/2011US8012997 Isoindole-imide compounds, compositions, and uses thereof
09/06/2011US8012996 Methods and composition for inhibition of angiogenesis
09/06/2011US8012995 Pharmaceutically active sulfonamide derivatives
09/06/2011US8012965 e.g. 1-(2-chloro-7-methylthieno[3,2-d]pyrimidin-4-yl)-N3-(5,7-ethano-5,7,8-trihydro-6-methyl-1,6-naphthyridin-3-yl)-1H-1,2,4-triazole-3,5-diamine; angiogenesis inhibitor, antiproliferative agent
09/06/2011US8012934 Small peptides and methods for treatment of inflammation
09/06/2011US8012464 Chimeric colony stimulating factor for use in treatment and prevention of cell proliferative, blood, inflammatory and nervous system disorders
09/06/2011US8012205 Cartilage repair and regeneration device
09/06/2011CA2493785C Pyrimidyl sulphone amide derivatives as chemokine receptor modulators
09/06/2011CA2465746C Hydrazono-malonitriles
09/06/2011CA2415228C Treatment of bone diseases
09/06/2011CA2373360C Carboxylic acid derivatives that inhibit the binding of integrins to their receptors
09/06/2011CA2336361C Cavity induced allosteric modification of intermolecular interactions and methods of identifying compounds that effect the same
09/01/2011WO2011106248A2 Trimethoxyphenyl inhibitors of tyrosine kinase
09/01/2011WO2011105424A1 Dendritic cell immunoreceptor stimulant
09/01/2011WO2010127195A3 Treatment of hemoglobin (hbf/hbg) related diseases inhibition of natural antisense transcript to hbf/hbg
09/01/2011WO2006039763A8 Vitamin d3 analogues for the prevention and treatment of bone disorders
09/01/2011US20110213036 Composition for prevention of tooth hypersensitivity
09/01/2011US20110213029 3,4-Di-Substituted Cyclobutene-1,2-Diones as CXC-Chemokine Receptor Ligands
09/01/2011US20110213002 Macrocyclic diterpenes for treating conditions associated with protein kinase c
09/01/2011US20110213001 Pharmaceutical compositions
09/01/2011US20110212998 Pyridine derivatives as s1p1/edg1 receptor modulators
09/01/2011US20110212992 Novel p2x7r antagonists and their use
09/01/2011US20110212989 Therapeutic methods and compositions involving isoflavones
09/01/2011US20110212974 Method for identifying compounds useful for treating and/or preventing disease-associated bone loss
09/01/2011US20110212970 Compounds that modulate intracellular calcium
09/01/2011US20110212962 P38 map kinase inhibitors
09/01/2011US20110212958 Fatty acid raloxifene derivatives and their uses
09/01/2011US20110212951 Human protein tyrosine phosphatase inhibitors and methods of use
09/01/2011US20110212945 Azabiphenylaminobenzoic acid derivatives as dhodh inhibitors
09/01/2011US20110212943 Novel bridged cyclic compounds as histone deacetylase inhibitors
09/01/2011US20110212923 Phosphate Derivatives of Substituted Benzoxazoles
09/01/2011US20110212914 Stabilized pentosan polysulfate (pps) formulations and methods of analyzing them
09/01/2011US20110212893 Nell-1 enhanced bone mineralization
09/01/2011US20110212882 Uses of kappa opioid synthetic peptide amides
09/01/2011US20110212193 Herbal Ointment for Musculoskeletal and Joint-Related Conditions
09/01/2011US20110212186 Composition for treating autoimmune disorders
09/01/2011US20110212184 Ultra Fine Dead Sea Mineral Compound and Method of Manufacture
09/01/2011US20110212166 Carnitine conjugates of adamantanamines derivatives as dual prodrugs for various uses
09/01/2011US20110212155 Flexible, Compressed Intravaginal Rings, Methods of Making and Using the Same, and Apparatus for Making the Same
09/01/2011US20110212153 Composite coatings and deposition methods